This weekend begins the final set of preparation races before the spring classics with Saturday’s running of the Monte Paschi Strade Bianche, Sunday’s start to Paris-Nice, and Tuesday’s opening of Tirreno Adriatico.
Monte Paschi Strade Bianche (Saturday, March 3rd)
Known commonly as “L’Eroica”, Italy’s Monte Paschi Strade Bianche is one of the newest races on the European calendar, but its roots are deep. Featuring over 57 kilometers of Tuscan white gravel roads, the race has quickly become one of the most popular events of the spring. Fittingly, the first five editions of the race have produced winners including Fabian Cancellara and Philippe Gilbert, the defending champion. As an added bonus, this year’s L’Eroica will be aired on live television, which means fans all around the world will have a chance to watch the action unfold.
Paris-Nice (Sunday, March 4th – Sunday, March 11th)
This year, the eight-day “Race to the Sun” has returned to its roots by including an individual time trial up Nice’s Col d’Eze for the first time since 2001. The race begins with a short, individual time trial that will start the GC sorting early, followed by several stages that will put the peloton’s echelon skills to the test. Expect sprinters and rouleurs to dominate these first few road stages.
As the race nears the Mediterranean, the mountains loom. Stage 5 finishes atop Mende’s Le Croix Neuve (the “Jalabert climb”), while Stage 6—a stage that begs for a Thomas Voeckler attack—features five categorized ascents on the road from Suze-La-Rousse to Sisteron. Stage 7 covers four more climbs, the last of which is the 1st Category Col du Vence, over 50 kilometers from the stage’s finish in Nice. Stage 8 will settle the GC; the Col d’Eze ITT leaves no margin for error. The climb is not incredibly steep, suiting more traditional time trialists best—pure climbers will need to forge their advantages earlier should they hope to emerge victorious.
Tirreno Adriatico (Wednesday, March 7th – Tuesday, March 13th)
Italy’s “Race of the Two Seas” begins Tuesday with a team time trial that will immediately place several GC riders at a disadvantage. Stages 2 and 3, while long and rolling, should both end in field sprints. Stages 4 and 5 see the mountains make their appearance, which should result in the first reshuffling of GC. Stage 6 features six laps of the circuit used for the 2010 Junior World Road Race Championship—another sprint is expected. The race concludes with a 9.3-kilometer individual time trial that will settle things once and for all.
With teams spread between two countries (or more in some cases) this is a ten-day period in which having a deep and talented roster is paramount to a team’s success. Let’s take a team approach to running down the favorites for this year’s editions:
BMC – BMC comes to Italy’s L’Eroica with defending champion Philippe Gilbert hoping to atone for a relatively poor showing in Belgium last weekend—or is he? He’s joined Saturday by George Hincapie, Greg Van Avermaet, Cadel Evans, and my pick for the win, Alessandro Ballan. Ballan has finished second in L’Eroica twice (2008 and 2011), and would certainly love to take his first victory since 2009 on home turf. Next week in Tirreno, BMC will be led by another returning champion: Cadel Evans. Evans was certainly unafraid that a win last year would ruin his Tour prep—look for him to use the 7-day event once again to test his form. The course certainly suits him.
In Paris-Nice, the squad turns to Thor Hushovd and Tejay Van Garderen, the former hunting for stage wins and form for the cobbled classics, the latter hoping to take another step in his development as a GC contender in major stage races. While a win might be out of his reach, a top-5 finish against some tough competition would be a step in the right direction.
By winning last year’s Criterium du Dauphiné, Team Sky’s Bradley Wiggins proved that he has what it takes to win major weeklong stage races. He’ll get another chance at Paris-Nice alongside Richie Porte and Rigoberto Uran. With Christian Knees, Danny Pate, Geraint Thomas, and Kanstantsin Siutsou fetching bottles and pulling back important breakaways, anything but a podium finish (or the win?) will be a disappointment for the British team. I wouldn’t be surprised to see both Wiggo and Porte hit the podium.
In Italy, the squad’s classics contingent will tackle Tirreno Adriatico, building form for Milan-San Remo and the cobbled classics. Mark Cavendish, Edvald Boasson Hagen, and Juan Antonio Flecha are the riders to watch here—expect at least a handful of stage wins and increased hype surrounding Cavendish and Boasson Hagen heading into Milan-San Remo.
Omega Pharma-Quick Step – Omega hopes to shrug-off its mediocre performance during the opening weekend in Belgium with wins at Paris-Nice and Tirreno Adriatico. Defending “Race to the Sun” champ Tony Martin will co-captain the squad in France alongside Levi Leipheimer (the winner of last month’s Tour de San Luis in Argentina), and French Champion Sylvain Chavanel. That said, I wonder if Martin would have been a better choice to lead the team at Tirreno Adriatico, a race with a TTT, an ITT, and less climbing than Paris-Nice. Leipheimer and Chavanel would have been fine on their own and the squad would have increased its chances of winning both races. Instead, the team will rely on Tour of Oman champ Peter Velits to lead the squad in Italy. He should do well assuming his form has improved since Oman.
Interestingly, for the first time since 2007, Tom Boonen will use Paris-Nice as his last stage race before the spring classics. Maybe he’s hoping for a return to 2005, when he won two stages in Paris-Nice on his way to winning both the Tour of Flanders and Paris-Roubaix.
Liquigas-Cannondale – Naturally, Liquigas is sending it’s two best riders—Vincenzo Nibali and Peter Sagan—to L’Eroica and Tirreno Adriatico. Both won stages at last month’s Tour of Qatar, with Nibali taking an impressive win atop Green Mountain, the event’s “Queen” stage. Eros Capecchi, (the winner of Sunday’s GP Lugano) will be at Tirreno as well and is certainly a candidate for stage wins and possibly a top-10 finish overall. These three as well as Moreno Moser and Daniel Oss are riders to watch in L’Eroica. For many fans, the possibility of a Moser winning on the strade bianche is too tantalizing to ignore.
In Paris-Nice, Ivan Basso and Elia Viviani will lead the way. Basso is peaking for the Giro and will likely be riding to build fitness, while Viviani—himself a winner of five events already this season—will be looking to the race’s field sprints in an attempt to prove he deserves mention alongside Cavendish and Greipel as one of the fastest men in the world.
RadioShack-Nissan – RadioShack-Nissan heads to Paris-Nice with a squad that we could very well see lining-up in Liège this coming June (remember, the Tour de France begins earlier this year due to the Olympic Games). Indeed, with Frank and Andy Schleck, Andreas Klöden, and Maxime Monfort all starting, it is quite possible that we could see at least three (I doubt we’ll see Andy Schleck do anything more than ride tempo for his teammates) of Bruyneel’s men finish inside the Paris-Nice top-10. Of the three, Klöden (last year’s runner-up) has the best shot at a victory. The German won Paris-Nice in 2000, largely thanks to his win in the Col d’Eze time trial, a stage making its return to the race this year. RadioShack’s winless thus far in 2012—look for Klöden to end that next Sunday.
As for Tirreno, RadioShack takes the approach of many teams, sending the bulk of its classics contingent to Italy. Fabio Cancellara won Tirreno in 2008 and has used the race in the past as the foundation of his classics campaign. While another GC victory might be out of his reach, Cancellara will certainly make his presence known. Daniele Bennati could also challenge for a stage win, while Chris Horner could be a surprising GC contender at such an early point in his season.
Rabobank – Rabobank has divided its resources fairly equally between Paris-Nice and Tirreno Adriatico, sending Bauke Mollema and Luis León Sánchez to France in search of high GC finishes and Carlos Barredo and Mark Renshaw hunting for stage wins. Sánchez already has four top-5 finishes in Paris-Nice, including the overall victory in 2009, but the event’s return to a more traditional parcours might hurt his chances. As for Renshaw, it is still a bit early, but I have a feeling he doesn’t have what it takes to be the team’s sprint captain—his past success looks to be more a product of HTC’s system than anything else. That said, a stage win in France would prove doubters like me wrong.
At Tirreno, Steven Kruijswijk will lead the team’s GC assault—the youngster has proven to like racing in Italy, as evidenced by his eighth-place finish in last year’s Giro d’Italia. Lars Boom is a candidate to win the final ITT (and GC?), while Matti Breschel and Michael Matthews should contend for stage victories as well. Breschel’s biggest priority will be putting the finishing touches on his form for the classics. His Omloop performance shows that he’s close, but still has room to improve.
Lampre – Lampre’s taking a two-pronged approach to the coming week, sending one squad led by Damiano Cunego to Paris-Nice and another led by Michele Scarponi to Tirreno. Scarponi won Tirreno in 2009 and narrowly missed defending his victory the following year when he lost to Stefano Garzelli by a fraction of a second. He’s looking forward to another assault on the Giro d’Italia this season (he finished behind Alberto Contador last year) and could certainly create some buzz with another strong performance next week. As for Cunego, he finished second in last Sunday’s GP Lugano, but has ridden inconsistently in recent years, making it hard to get a handle on his chances in the Ardennes. A strong Paris-Nice would certainly restore our faith in the Italian. Diego Ulissi bears watching for stage wins as well.
Movistar – Alejandro Valverde has returned from suspension to win three races already this season. He leads Movistar in France. Valverde has a Paris-Nice stage win and a (voided) second-place overall finish on his resume, but I have a feeling this year’s course—and the competition—might prove too tough for the Spaniard. He’ll be a contender, but I doubt he’ll win the race. Surprisingly for the Spanish team, Movistar’s best chances for a win this week might come in Italy, where Giovanni Visconti—the reigning Italian champion—will look to show his home fans that his emigration was not a mistake. Look for him to be at the forefront during both L’Eroica and Tirreno, where Visconti might be better served going for stage wins than a high overall finish.
Acqua e Sapone – Stefano Garzelli is justifiably disappointed to have seen his team left uninvited to the 2012 Giro d’Italia. After all, Garzelli won the Giro in 2001 and took home the mountains classification last year. Instead the Italian will have to settle for Tirreno Adriatico, a race he won in 2010—barely. Garzelli is one of those riders that you can always count on to perform well in certain races. In this case, he’s a certain contender for the overall victory by virtue of the simple fact that Tirreno’s the biggest race on his program—at this point at least. While other riders might be looking past it to more important events, Garzelli has been racing and training knowing that this might be his best (and only) chance for a major victory this season. And for a rider who’s been the subject of mid-season transfer rumors, a win next week might go a long way to making such a move come to fruition.
Katusha – Denis Menchov will lead Katusha in Paris-Nice. And while it’s anyone’s guess as to his current level of fitness, it’s certainly a race that suits the Russian’s strengths. In Italy, Joaquim Rodriguez and Oscar Freire will lead the way, both looking for stage wins. The race’s two time trials will likely be too much to make Rodriguez a candidate for the overall victory. Freire actually won Tirreno back in 2005, taking advantage of field sprints and time bonus to win one of the event’s flatter editions. This year, the Spaniard has included the race on his “farewell” tour as it gives him the best preparation for what could be his fourth victory in Milan-San Remo.
Garmin-Barracuda – I suspect Garmin-Barracuda will be seeking stage wins in both France and Italy next week, with Ryder Hesjedal a strong contender for Saturday’s L’Eroica. The former mountain biker scored three top-10 finishes on the strade bianche from 2008 through 2010, and with the pressure of contending the Tour de France off his shoulders, might find himself “riding a bit lighter” now. Johan Vansummeren and Tyler Farrar will join the Canadian in Italy as both riders continue to build for the classics. Farrar’s still winless in 2012; that could easily change in Tirreno.
In France, Omloop-winner Sep Vanmarcke will join Heinrich Haussler and Christophe Le Mével at Paris-Nice. Haussler is also winless this season and wants to prove that his fantastic 2009 season was more than just a flash in the pan—a solid Paris-Nice will a long way toward accomplishing his goal. Also worth noting: Thomas Dekker makes his World Tour return in Paris-Nice as well.
Saur-Sojasun – Jerome Coppel won this season’s Étoile de Bessèges and then finished third at the Ruta del Sol. A talented climber and time trialist, the young Frenchman hopes to continue his progression with a podium finish in Paris-Nice. If he does, look for the rider (with a 5th-place finish the 2010 Dauphiné and a 14th-place finish in last year’s Tour on his resume) to become the new darling of France’s cycling media.
Project 1T4i – 1T4i’s Marcel Kittel and John Degenkolb will try for stage wins at Paris-Nice in the hopes that they can impress the ASO enough to earn a Tour de France wild card invitation. Kittel did well against some tough competition in Oman; he’ll face a more intense level of competition in France.
Astana – Astana has yet to win a race this season and hopes to soon end the streak. The squad turns to Roman Kreuziger, Maxim Iglinskiy, Borut Božič, and Enrico Gasparotto in Italy, and Janez Brajkovič
in France. Brajkovič won the Dauphiné and—on paper at least—should enjoy a Paris-Nice that looks tailor-made for him. Maxim Iglinsky won L’Eroica in 2010 while Božič should be a contender in Tirreno’s field sprints. As for Kreuziger’s chances at a high overall placing, I suspect he’ll test his form without ruining his preparation for this year’s Giro.
GreenEdge – GreenEdge is feeling the pressure that comes with being a new (and hyped) World Tour squad. In Paris-Nice, Tour Down Under winner Simon Gerrans will attempt to defend his lead in the World Tour standings while building fitness for the Ardennes classics. Meanwhile, Matthew Goss, Stuart O’Grady, and Sebastian Langeveld lead the Australian team’s Tirreno squad. Goss has been conspicuously silent so far this season—he needs to show himself soon if he wants to a chance to defend his title at Milan-San Remo.
1-Kite Dark Horses
Colnago-CSF – In 1975, Giovanni Battaglin won a stage of the Giro d’Italia that tackled the Prati di Tivo, the climb that concludes Stage 5 in Tirreno. Look for Battaglin’s nephew Enrico to do his best to honor his uncle’s legacy with a stage win of his own—or a win in L’Eroica. Sasha Modolo should also be a threat in Tirreno’s sprint finishes.
Colombia-Coldeportes – Colombia-Coldeportes makes its World Tour debut at Tirreno Adriatico with Fabio Duarte the team’s best chance for a stage win.
Team Type 1 – Sanofi – Jure Kocjan finished fourth in last year’s L’Eroica. He’s been sick as of late, but alongside Danielle Colli, he could turn some heads Saturday.
At L’Eroica, I think Alessandro Ballan will give BMC its first victory of the season over Ryder Hesjedal and Enrico Battaglin. Ballan’s in-form, motivated, and has the experience necessary to win a race on the strade bianche. In Paris-Nice, Andreas Klöden will take his second title in the “Race to the Sun” over Leipheimer and Valverde, while in Tirreno Adriatico, Nibali will defeat Evans and Garzelli.
What about your picks? Share them below.
Image: ©BMC/Tim de Waele
Many fans couldn’t care less about the first four weeks of the professional cycling season. Part of me can’t blame them. I mean seriously—Argentina? Qatar? Oman? And of these early races, only a few feature terrain that puts the majority of the peloton into the red zone. In most cases, crosswinds and cold weather do more damage than the actual racing does. Even Southern Europe was not immune, as record low temperatures turned most races into leg-warmer contests where the rider able to stay the warmest the longest often found himself on the top step of the podium. You’re forgiven for not caring.
On the other hand, the first weeks of the season offer our first glimpses of new riders and teams, many of whom are eager to impress following seasons that fell short of expectations. These early tests also offer pundits a chance to determine which riders are starting the year in good shape, making them possible contenders for the season’s first major rendezvous in Belgium, France, and Italy.
So whether you weren’t paying attention either by choice or by accident (and before the “real” season begins this Saturday with the Omloop Het Nieuwsblad), here’s a quick rundown of what you missed, packaged together in a little game I like to call Win, Lose, or Draw (no Dom DeLuise required).
Omega Pharma-Quick Step (Win) – Belgium’s Omega Pharma-Quick Step has enjoyed a terrific start to the season—one that calls to mind the exploits of HTC-Columbia/High Road. At this point in the season it’s usually one or two riders that have won the bulk of any one team’s race victories; in Omega Pharma’s case, six riders have shared the spoils (Chicchi, Boonen, Fenn, Leipheimer, Ciolek, and Velits), with two more (Martin and Trentin) just missing wins themselves. If the team continues its torrid pace once the “real” racing begins in earnest, they could easily end the season as the year’s top-ranked squad.
Lotto-Belisol (Lose) – Andre Greipel has already won five races for the restructured Belgian squad and Tour-hope Jurgen Van den Broeck looked strong in Qatar; but the team also lost Jurgen Roelandts after a crash in Stage 1 of the Tour Down Under. Roelandts was the team’s best hope for the cobbled classics, an important block of races for any Belgian team—especially one trying to keep up with Omega Pharma-Quick Step’s early season success. Without Roelandts, Greipel might need to ride himself into contention for the flatter classics—Milan-San Remo comes to mind, but Ghent-Wevelgem and the Grote Scheldeprijs might be better bets for the German speedster.
BMC (Draw) – BMC made the biggest splash this past off-season, but they’re winless so far in 2012. That said, with men like Gilbert, Evans, Hushovd, and Van Avermaet on the roster, there’s hardly good reason to worry. This weekend’s Omloop will be our first opportunity to see some of the squad’s biggest names racing au bloc. And with two former winners and several other possible contenders on the roster, don’t count them out.
Tom Boonen (Win) – Omega Pharma’s most successful rider thus far has been Tom Boonen, a welcome sight considering the Belgian’s frustrating past two seasons. Boonen’s sprint speed appears to have returned, but perhaps more importantly, so has his confidence. Here’s a an interesting bit of trivia for those hoping to see Tommeke add another Flanders or Roubaix to his resume: each year that Boonen won the overall title at the Tour of Qatar, he took one of the two cobbled monuments as well.
Southern European Races (Lose) – There was a time when Mallorca, Southern France, and Italy were three of the sport’s most weather-friendly early season locales. But not this year as frigid temperatures and snow forced the abbreviation or cancellation of reventsaces in all three countries. But don’t get your hopes up for an “epic” weekend of racing in Belgium—the forecast calls for dry, sunny conditions. Go figure.
Mark Cavendish (Draw) – Two stage wins in Oman plus a bout of sickness and a crash amount to a draw for the reigning world champ. On the bright side, Cav’s wins indicate that his Team Sky lead-out train is coming along quite nicely.
Jonathan Tiernan-Locke (Win) – Easily the season’s biggest surprise has been Endura Racing’s Tiernan-Locke, the winner of both the Tour Mediterranean and the Tour du Haut. The British rider won each event’s “queen” stage and in doing so, the overall titles as well. Thanks to his victories, Tiernan-Locke has apparently attracted the attention of several World Tour squads. Look for him to finish the season in a new uniform.
Greenedge (Lose) – Australia’s Greenedge Cycling team won its first two important goals of the season—the Australian Road Race Championship and the Tour Down Under—but have since fallen flat in their inaugural World Tour season. With so many flat races on the schedule (and shortened ones at that), you have to think that a roster with such an impressive set of speedsters would have produced more results. But let’s be fair: many upstart World Tour squads (especially those created out of thin air) have often struggled to find consistent results during their first seasons (Team Sky and Slipstream come to mind) but have gone on to win several major races.
Alberto Contador (Draw) – For Alberto Contador’s fans, his two-year retroactive suspension counts as a loss. To proponents of a cleaner sport though, it’s a clear win. But at the end of the day, Contador’s suspension and the loss of his titles dating all the way back to the 2010 Tour de France amount to nothing more than a draw. First of all, Contador’s reputation seems to have survived the court of public opinion. Second, he’ll be back and racing in time to win his second Vuelta a Espana—which just about everyone expects him to do easily. Even his sponsor still supports him—a smart move considering he’s still likely to command a tremendous salary in spite of his suspension.
Elia Viviani (Win) – I identified Viviani as one of several young Italian sprinters to watch as part of my Season Preview a few weeks ago. So far, the Liquigas-Cannondale rider has lived-up to my expectations. Viviani’s already won five races, and until the win by his teammate Moreno Moser (yes, he’s Francseco’s nephew) in Sunday’s Trofeo Laigueglia, he was undefeated on home soil. If he manages to take a stage or two in next month’s Tirreno-Adriatico, look for Viviani’s name on the list of contenders for Milan-Sam Remo.
Rabobank (Lose) – Last year, Rabobank had already won nine races by this point in the season. This year, they’ve won nothing. Worse still, Oscar Freire—the man they let go to make room for Mark Renshaw—has already won two races for Katusha. Luckily, Matti Breschel seems to be healed and ready to contend this weekend in the Omloop Het Nieuwsblad, a race Rabobank won last year as well. Too bad the winner (Sebastian Langeveld) now rides for someone else (GreenEdge).
Alejandro Valverde (Draw) – Similar to Contador, Valverde’s status depends entirely on your perspective. For many, the Spaniard’s return to racing leaves a black eye on the sport and its ability to fairly mete out justice. For others, it simply marks the return of one of the sport’s most talented and exciting riders, someone capable of challenging Philippe Gilbert in the Ardennes. And while he’s already won two races, he’s still a long way from redemption.
French Youth Movement (Win) – It was also good month for young Frenchman as Europcar’s Pierre Rolland, Saur-Sojasun’s Jerome Coppel, and FDJ-Big Mat’s Arnaud Demare and Nacer Bouhanni took wins. While Rolland and Coppel have bright futures as stage racers, Demare (the reigning U23 World Road Race Champion) and Bouhanni give the nation two young sprinters to root for at Paris-Nice.
Saxo Bank (Lose) – We’ll know for sure sometime in March, but if the team’s hearing before the sport’s Licensing Commission on February 27 doesn’t go well, they could find themselves on the outside looking in at the rest of the World Tour. Bjarne Riis has struggled in the past to find sponsors to support his program; a demotion certainly won’t make life any easier.
Share your early season Win, Lose, or Draw contestants below!
Follow me on Twitter: @whityost
Image: John Pierce, Photosport International
We usually have to wait a few weeks to see the sport’s biggest stars take their first scalps of the season—but not this year. Andre Greipel (Tour Down Under), Alejandro Valverde (Tour Down Under), Oscar Freire (Tour Down Under), Levi Leipheimer (Tour de San Luis), and Alberto Contador (Tour de San Luis, later DQ’ed) have all opened their 2012 accounts—and in some cases, more than once. Even the reigning world champion has enjoyed some success, as Team Sky’s Mark Cavendish took his first two wins of the season in Qatar this week.
But the by far the season’s biggest success story—so far, at least—has been Omega Pharma-Lotto’s Tom Boonen. Boonen’s already won four races in 2012 including two stages and the overall at the Tour of Qatar. Boonen’s also proven to be a dedicated teammate; he helped Francesco Chicchi win two early stages in Argentina before taking the final stage himself.
More than anyone else this season, I’m expecting (and hoping for) big things from Boonen. One of the sport’s most exciting cobbled hardmen, Tommeke already has three wins in Paris-Roubaix and two in the Tour de Flanders. But Boonen’s current streak leads me to believe he’ll be the big favorite when the Belgian season opens two weeks from tomorrow at the Omloop Het Nieuwsblad—one of the few cobbled races Boonen has yet to add to his resume. As long as it doesn’t hurt his chances to win another Monument, I’ll be rooting for him there.
Which leads me today’s question: who’s the one rider you’re hoping will find the most success in 2012 and why?
Follow me on Twitter: @whityost
Image: John Pierce, Photosport International
When I woke this morning, the first thought I had was, “What other bad news will be revealed today?” I’m not one to experience ennui, but this morning, I didn’t have any energy to go for a ride, didn’t want to look at the news and really only wanted to hang out with my family and enjoy a leisurely morning.
None of those things happened, mostly because I did look at the news. For those who aren’t keeping score:
1) The Tour de France champion tested positive.
2) The president of the UCI denied that Contador was being investigated the day before he admitted the existence of said investigation.
3) The Vuelta’s second place and a teammate tested positive.
4) The home of Riccardo Ricco has been raided and unless Italian police don’t know what aspirin looks like, something suspicious was found in a cabinet belonging to a guy who has been convicted of doping once before.
5) Oscar Sevilla has tested positive yet again.
6) The sister of the winner of the Giro d’Italia isn’t permitted to attend sporting events because of her role in the distribution of doping products.
7) Ex-Oakley employee Stephanie McIlvain put her finger in the dike against the many accusations against Lance Armstrong.
8) Allen Lim told a grand jury that he wasn’t hired to help Floyd Landis dope.
9) Operacion Puerto is to be closed and all the evidence destroyed. The truth won’t out.
The only good news for a jingoistic Yank rests on the shoulders of the world’s third-most-popular Taylor (let’s not forget Swift and Lautner), a 20-year-old who we all must hope never comes to the attention of the Eugenics movement. (If you can breed dogs, you can breed people, right?) Taylor Phinney’s gold and bronze medals in the U23 World Championships aren’t news, they are simply confirmations of his talent. With two more years in that category at the world championships, he could wind up the most-medaled U23 rider in history.
Let’s cover this in reverse order: The blood bags are going to be destroyed and we’ll never know the true depth of Fuentes’ business, but it a way, it’s such old news suspending a rider now based on that case seems kind of irrelevant. What’s significant here is the lack of institutional will to get to the truth and clean up sport. This is going to haunt us like a drunken kiss at a New Year’s Eve party.
How often does a job description reflect the job as performed? Who hasn’t had additional had additional duties thrust upon them out of necessity. The subtext here is that Allen Lim may not have admitted all the ways that he assisted Landis. Lim told ESPN.com, “When I worked with Floyd, I repeatedly told him that he didn’t need to dope and should not dope, and I was absolutely not hired to help him to do so.” Okay, so you weren’t hired to help him dope … but did you? Landis may seem kinda desperate and crazy, but no one has suggested that he’s trying to slaughter innocents. Are we really to believe that Landis would screw saint? That doesn’t fit the bill.
Despite the existence of an audio tape made my Greg LeMond in which Stephanie McIlvain reveals that she did hear Armstrong admit to using performance-enhancing drugs, the former Oakley employee—whose husband is Oakley’s VP of sports marketing—testified to a grand jury that she had no knowledge of Armstrong’s use of drugs or that she heard him admit to using them during a meeting with doctors at which Frankie and Betsy Andreu were present and which they claim she was present as well. One wonders what other questions she was asked besides those two; presumably it shouldn’t take seven hours on the witness stand to say “no” twice. While McIlvain has certainly protected Oakley’s (and by extension, Armstrong’s) interests, investigator Jeff Novitzky has secured perjury convictions against athletes who lied to a grand jury.
Elisa Basso, sister of Giro winner Ivan Basso and wife of former pro Eddy Mazzoleni was snared along with her husband as part of Operazione Athena. Mazzoleni was given a suspended sentence for his role in the drug dealing, while Elisa received a ban that stopped just shy of saying she can’t watch sports on television. Not only can she not work for CONI or any of the national governing bodies for sport in Italy, she can’t attend the events or even enter a place frequented by athletes or their coaches. And competing herself? No chance.
Oscar Sevilla, who tested positive for the EPO masking agent hydroxyethyl starch (HES) has been allowed to return to racing until his B-sample analysis is returned. Technically, the product isn’t banned, but its only use is to mask doping and it can only be administered by transfusion, which itself, is not permitted. Sevilla told Cyclingnews.com, “Let’s say that justice is done because there is no reason to suspend me. There can be no direct doping case, as with a forbidden substance, since hydroxyethyl is not on the banned list.” Even weirder, he added, “I take all the steps and face the situation. Ideally, the B sample will be negative. But if not, then the cycling federation will meet to decide on my case.” Ideally? Methinks the rider protest too little.
Some 50-odd tablets of unknown composition were found by Italian police in a cabinet at the home of Riccardo Ricco. Naturally, Ricco—let us not forget Ricco’s previous suspension for CERA use—claims they are nothing elicit.
Ezequiel Mosquera—the darling of the 2010 Vuelta—and his teammate David Garcia have both tested positive for HES—the same stuff Sevilla tested positive for—a substance of use exclusively to cyclists trying to hide evidence of transfusions or EPO use. Hmm, every positive for HES happens to be with a Spanish cyclist. Coincidence?
Credit or blame (depending on your outlook) that we know anything about Alberto Contador’s positive test can be given to German journalist Hans Joachim Seppelt with the news organization ARD. He specializes in doping stories and learned of Contador’s positive (presumably from the Cologne lab that did the testing) before the UCI had announced anything. When he approached Pat McQuaid, the UCI president denied knowing anything, yet less than 24 hours later a press release was issued. Based on what we know of the case—that clenbuterol and traces of a plastic used in transfusion bags were found in Contador’s urine—there seems to be ample evidence that a suspension is in order while the case is adjudicated. The question is why two months passed since the end of the Tour de France and the public is just now finding out; even Contador knew of the test result in late August.
Of course, the big news of the week is how Alberto Contador not only tested positive at the Tour de France, but the UCI gave him time to prepare a defense. While Mosquera and Garcia found out about their positives through the media, Contador got the bro’ heads-up.
Add to this the just-announced positive of Margarita Fullana for EPO. Fullana would have us believe she only used EPO this year, in which she got virtually no results, and not in previous years when she was blowing by the competition like the Road Runner going by the Coyote. Totaled, we have four positive tests announced in less than a week. Curiously, all of them are by Spanish riders. This little detail seems to suggest that Spain has a bigger problem with doping on a cultural level than any other nation in cycling. While it’s impossible to say that there is a permissive attitude toward doping in Spain, that nation is the highest ranked in cycling according to the UCI with 1868 points, compared to Italy’s 1071 and Belgium’s 882—and that’s even after points were subtracted following Alejandro Valverde’s suspension.
According to a poll in the Spanish paper Marca 78.5 percent of the Spanish people believe that Alberto Contador is innocent of doping. But that figure isn’t quite right. Newspaper polls are notoriously unrepresentative of the actual population; it’s much safer to say that of cycling enthusiasts who read Marca 78.5 percent believe Contador is innocent. Theoretically, this group is better educated about doping and ought to feature a higher percentage who accept that it’s very likely Contador received a transfusion during the Tour de France. Given the number of American cycling enthusiasts who can’t even contemplate the possibility that Mr. Big Shot doped, maybe we shouldn’t be too surprised by this.
Based on last week’s news, I’ve drawn three conclusions:
1) Clenbuterol is the red herring in Contador’s doping case. There’s a reasonable argument to be made that Contador didn’t intend to dope using clenbuterol, as well as a reasonable argument that strict liability is an absurd standard by which to judge an athlete. However, the plasticizer present in Contador’s sample cannot occur from an unintended source. He got a transfusion and this, ladies and gentlemen, should not surprise us. This is how the game is played currently. I hate re-writing record books and results, but if we want a clean sport, chasing brilliant leads like this is how we’ll get there.
2) McQuaid is a bigger problem than I thought and the UCI needs to clean house. Of course, that’s like suggesting to a hoarder that what they should do is toss out the junk and sweep the floor. There’s a fundamental problem with the UCI’s mission. It is charged with governing the sport by overseeing the promotion of races. If the sport of cycling suffers as a result of poor race promotion, the responsibility is the UCI’s. However, it is also charged with disciplining athletes who dope. Punishing your biggest stars is a conflict of interest if ever there was one. Clearly, WADA should have jurisdiction over informing the riders of positive tests and disciplinary proceedings should be turned over to CAS. After all, if WADA was charged with disciplining the athletes they tested, there would never be another false positive or flawed administration of a test. They would bat 1.000 against riders, which is pretty much where things stand.
3) Something’s rotten in Spain. Again, it’s impossible to say where the root of the problem lies, but it strikes me as cultural on some level. Writing that troubles me. I’m not a bigoted guy, but we’ve seen statements from the head of the Spanish federation defending Valverde, an unwillingness by the Spanish judiciary to get to the bottom of Operation Puerto, Spanish cyclists testing positive at a rate far higher than cyclists from any other country. Of course, while it’s nice to have someone call out the Spanish federation, even if it is Pat McQuaid, what we need is a dog with some teeth to go after them.
And now Alberto Contador is threatening to quit the sport. Isn’t that like saying you hate the movies after being grounded? Seriously, though, has he read the Wikipedia entry on Jan Ullrich? Changing nationalities and retiring didn’t really end the scrutiny of his activities.
Lingering in the background of all this doping news is a thought I hadn’t been willing to articulate until now. The French are the only nation of cyclists incapable of producing a rider able to stand on the podium of their national tour. I’ve come to the conclusion that French cycling (ranked 14th among nations) sucks because they—more than any other cycling superpower—really took to heart the whole no doping thing. Remember, we haven’t seen a Frenchman on the podium of the Tour since the Festina Affair.
Image: John Pierce, Photosport International
If you’ve raced bicycles before then you’ve probably had the experience of multiple near misses at a race before scoring the big V. In this, you have something in common with Cadel Evans. Gloat now. Right now. You, I and the rest of the mortal world won’t get too many chances to share something in common with the current World Champion beyond such basics as peeing standing up (apologies to the women readers). With three top-10 finishes to his credit he knew how the final kilometer could go wrong even for the very strongest of riders.
Patience isn’t a word that anyone ever uses in conjunction with a Spring Classic. Appropriate tags for a Spring Classic are ‘attack,’ ‘limit,’ ‘suffer,’ ‘blow up’ and ‘head down.’ And that’s where Evans’ tactical savvy and experience paid off for him today.
And while not much has been said, Chris Horner delivered another great ride to finish seventh, the second-best performance by an American at the race. Not bad for 38.
There were a number of riders who looked strong, strong enough to win the day. And that Caisse d’Epargne didn’t take the day was perhaps a bit of a surprise for them.
Valverde rode like it ought to be his race. Unfortunately, he was the only person thinking that.
Evans has often been criticized for not riding aggressively enough to win more races. And maybe he has lacked the killer instinct at times. The 2010 Fleche-Wallonne begs a question.
Did winning a World Championship actually teach Evans an important lesson about how to win? Even though the most common criticism is that he never seemed to attack, the great secret of Fleche-Wallonne is to wait to attack, to wait until you would have lost any other race. Just ask Alberto Contador.
With 500 meters to go Contador looked to have it in the bag. Unfortunately, our TVs are still not equipped with Sony’s patented “Lactic-acid-ometer” to show us just how close to blowing a rider really is. Of course, the difference between insanely hard and completely done is about four watts.
The images are in sequence and encompass only the final trip up the Mur de Huy. It’s amazing to watch how short a distance Evans needs to close the gap to Contador and Igor Anton, all the while holding off Joaquim Rodriguez.
Alternate theory: Evans is still getting it wrong, but now he’s just getting the curse of the rainbow jersey wrong and he’s winning instead of losing. Imagine the shock Contador experienced when he noticed the rider passing him was Evans.
Images: John Pierce, Photosport International.
There have been entirely too many doping storylines in cycling lately. We’ve had the Alejandro Valverde problem, the Danilo DiLuca suspension and Ricardo Ricco’s imminent return to the sport. His girlfriend, Vania Rossi, tested positive for the same drug—CERA—for which he was suspended, and he subsequently dumped her, months after she gave birth to their child. Bernard Kohl has opened a bike shop and seemingly ended his monthly interviews that teased out details of his doping regimen like bread crumbs for birds. Stefan Schumacher continues to fight his suspension.
And today we mark six years since the lonely death of Marco Pantani. Like Pantani, Jose Maria Jimenez was a once-talented climber who, according to circumstantial evidence, became addicted to cocaine and ultimately overdosed on the drug, cutting short a life that should have been full of promise, even after ending his career as a racer. It’s little wonder that so many cyclists reacted with horror at the news of Tom Boonen’s flirtations with the nose candy.
The constant parade of doping stories has made many cyclists weary of ProTour racing, but worse, it has changed our understanding and perception of racing in the past. We now accept Fausto Coppi’s statement about always doping when he raced, rather than discount it, which is certainly what I did when I first read the statement in the 1980s.
And while many of us took Eddy Merckx at his word when he insisted he had used nothing out of the ordinary when he was ejected from the 1969 Giro d’Italia, we have come to see that event was but one of three positive tests he gave in his career. Certainly questions abound to this day about that Giro test, such as no counter-analysis and questionable chain of custody, it’s easy to see the positive as a not uncommon occurrence in an era ripe with amphetamine usage. Why should Merckx be any different; after all, he ranks as the most successful cyclist of all time. Are we to think he was the only clean champion of his generation?
Looking back on riders I have admired—Greg LeMond, Eddy Merckx, Bernard Hinault, Fausto Coppi, Miguel Indurain, Lance Armstrong, Andy Hampsten, Richard Virenque, Marco Pantani, Johan Museeuw, Moreno Argentin, Frank Vandenbroucke, Jan Ullrich, Tyler Hamilton, Floyd Landis, Alejandro Valverde, Danilo DiLuca and plenty more, what strikes me is that only two of these names have never been broadly accused or convicted of doping—LeMond and Hampsten. Were we to take every doping allegation out there as fact (save anything Armstrong has said to or about LeMond), we might be forgiven for coming to the conclusion that Hampsten’s win in the Giro was the last by a clean rider, as was LeMond’s last win at the Tour.
I admit, every time a new rider comes thundering onto the scene, I have moments (roughly one for every win) when I wonder, “Is this guy clean?” Even without a single positive test to implicate the rider, I can’t help but wonder if some new phenom is our next Riccardo Ricco or Bernard Kohl. To wonder such a thing is reputation assassination, even if I don’t share it with anyone else.
But this youngest generation of riders, riders who came onto the scene after the EPO problem had been identified, after the test had been devised, those are the guys who scare and upset me. It’s little wonder to me that any rider still in the game now who was there for the rise of EPO and the team podium sweeps of the ’94 Fleche Wallonne (Gewiss-Ballan) and the ’96 Paris-Roubaix (Mapie-GB) might still not be conforming to the memo. But what really troubles me are the new riders who still pursue EPO and its newer variant, CERA. Just as we think we’re making progress in doping thanks to programs such as those run by Bjarne Riis and Jonathan Vaughters, some new rider gets suspended for a drug that we have come to believe is easy to catch.
As a result, many of us have turned our backs on past performances that gave us chills, left us cheering at the TV and maybe even caused us to put up a poster of the rider in our dorm room or garage. Those were the days.
Museeuw’s win at Roubaix in ’96 came at the end of arguably the most dominant ride by any team in the history of the Hell of the North. Now we know that it was EPO that gave their performance the appearance of a Ferrari racing a Yugo.
In comments here at RKP, we’ve seen how many of your have turned against not just Lance Armstrong, but other riders we know to have doped: Marco Pantani, Frank Vandebroucke, Tyler Hamilton and more.
I realized not too long ago that if I disavow every performance that involved doping, I’d be stripped of almost every race that I ever cared about. I’d even be stripped of LeMond’s last-minute win at the 1990 Tour de France because the guy he beat—Claudio Chiappucci—was on EPO. Without him and that drug, LeMond’s win would have been much more dominant. And don’t get me started about 1991.
Despite the lies, the doping, the inability to know who was truly the best on the day, I don’t want to lose the wonder and awe I felt when I saw those performances. If I turn my back on every one of those performances in bitterness, it’s tantamount to saying of your ex, “I never really liked her.”
Those experiences, the wonder I felt at watching Richard Virenque or Floyd Landis winning in Morzine in 2003, the jubilation I felt at Tyler Hamilton’s win in Liege-Bastogne-Liege, my astonishment at Armstrong’s win at the Tour in ’99 or my awe at any of Johan Museeuw’s wins at Paris-Roubaix were experiences of genuine and honest emotion on my part. While I have a different understanding of those performances today, and my feelings for those racers may have changed somewhat, I’ve decided I won’t let anyone, any new revelations, change how I remember those performances.
I can’t tell anyone else how to feel about those performances. The bitterness some of you feel at the betrayal of learning some win was doped is as valid an emotional experience as any jubilation I’ve felt for the same performance.
But for those of you who have felt frustration and confusion with each new revelation, I offer my perspective as a different way to process your feelings. I’m not suggesting we capitulate and just give in to enjoying doped riding; like each of you, I want a clean sport, full stop.
Society changes and what we tolerate changes as well. Thomas Jefferson had slaves. I can’t endorse his ownership of a person, but that act shouldn’t erase the work he did in establishing the United States’ democracy.
I truly believe cycling is changing for the better and that doping is on the decline. It is a scourge, though, that we should not fool ourselves into thinking will ever be eradicated. We should not accept the doped performances of the past out of inevitability and resignation, but rather because they inspired us in our own riding. And if we rode with honesty and conviction, then some good came from those tarnished wins.
Image: John Pierce, Photosport International
As October begins to blow leaves from the trees and the European season winds down, there are two big races left in 2009. The first is Paris-Tours. The second is the race to pry Alberto Contador out of his Astana contract. This is a race with a number of riders, all hoping to cross the line with 2010’s presumptive Tour de France favorite on their roster.
First, Contador has a year left on his Astana contract, so Astana have to be favorites to keep the mercurial Spaniard. This is technically true. But if the Kazahks lose their ProTour license, and UCI head Pat McQuaid has indicated that the governing body is evaluating Astana’s licensure, they might be inclined to cash out their assets (i.e. Contador) and pull out altogether.
Whatever posturing Alexander Vinokourov has done in his comeback from a two-year doping ban is just that, posturing. No one is going to run a pro team on the back of a 36-year-old unrepentant doper. If they’re daft enough to soldier on, and remember they’ll need to sign a full roster of riders after the Lance walked off all the strongest riders for his new RadioShack team, they’ll do so knowing they’re not likely to get invited to the Tour de France, both because of Vinokourov’s past and they’re own dearth of quality riders.
Next in line is Caisse d’Epargne, and they don’t need Contador unless they believe Alejandro Valverde’s troubles with the doping authorities aren’t going away. They’ll want a horse in the Grand Tour GC race in that case. I suppose they might think of sweeping the Tours with Valverde and Contador doing the podium tap dance. That would be a good trick, but does anyone think they have the support team to do that? No. I don’t either.
Garmin-Slipstream, who won’t talk about signing Contador except to say how awesome that would be, don’t need Contador either, unless they think Bradley Wiggins is going to force his way out of the team and into a Team Sky uniform. Sky is a British team. Wiggins is British. They can offer him a uniform that doesn’t look like a preppy car accident. You can see why Wiggins would want that. In the event of Wiggo’s defection, then Jonathan Vaughters might do worse than picking up Contador as a replacement.
Then there’s Quick Step. Now this one really makes sense to me. Packed full of talent for one-day Classics, the Belgian squad only needs to add a real GC man to strike bowel-clenching fear into the rest of the peloton. Signing Contador will cost money Quick Step doesn’t have, but the Spaniard is a bankable asset. Perhaps the Belgian floor maker can secure an additional loan to do a deal. Patrick Lefevre, the team’s manager, has even promised to hold five roster spots open to hire support riders just for Contador. Really, it’s shameless.
Finally, there has been talk of Contador forming his own team, but with the Shack and Team Sky entering the fray, the ProTour simply won’t support a third brand new team, even if Contador and his handlers could pull together a passable roster in time, which they can’t. So forget about it.
These are the moving pieces: Astana’s license, Alejandro Valverde’s DNA, Bradley Wiggins’ sense of national pride, Jonathan Vaughter’s argyle sweater vest, Quick Step’s line of credit.
Everything depends on Astana. Allegedly they’ve made all the financial guarantees necessary through the end of 2010, so there oughtn’t be a repeat of 2009’s bounced paychecks. But between 2009’s foibles, the return of the pariah, Vinokourov, and the loss of so many top-riders, it might be too big an ask for the Kazakh’s to go on. Once the door is open for Contador to leave, and believe me it will be, then it’s race on.
If the Kazakh consortium behind Astana is smart, they’ll let Contador’s price rise over the next month before doing a deal. As the holiday lights go up, what Astana can hope to get in return for their prize pony will dwindle. Teams will have to finalize rosters, make out budgets and firm up plans. Astana will be seen as desperate if they hold on too long.
It may well be that Garmin and Caisse d’Epargne are just waiting to see what happens with Wiggins and Valverde before tabling their best offers. Quick Step’s best bet is to make a deal before one of those other dominoes falls, because they likely don’t have the cash to compete otherwise.
The British have given us this expression “Elephant in the room” (also, according to Wikipedia, “elephant in the sitting room”, “elephant in the living room”, “elephant in the parlor”, “elephant in the corner”, “elephant on the dinner table”, “elephant in the kitchen”, and “elephant on the coffee table”). And regardless of which room or on what piece of furniture the aforementioned pachyderm has chosen to rest his weary bones, the point is that the elephant is there, obvious, in plain sight. And yet, no one wants to talk about the elephant.
For a century, doping has been the elephant in cycling’s living room. In the early years of continental competition, riders were frequently charged with having cheated by drinking brandy during stages of grueling races. Later, amphetamines and cortisone crept in, and many of cycling’s greats were believed to be “doped” in these ways, including Fausto Coppi, Eddy Merckx and Jacques Anquetil. In the 1967 Tour de France, Tom Simpson died on the side of the road on Mont Ventoux, after mixing amphetamines with alcohol; his witches’ brew foreshadowed the even crazier concoctions such as pot belge that were to come. The sense that doping is a problem in modern cycling only is a misconception.
This elephant has always made himself comfortable, either on the chaise longue or perched happily next to the ottoman.
The British gave us the expression, and the Spanish have given us Alejandro Valverde, the top-ranked cyclist in the world last year by the UCI. Valverde is that rarest of riders, a strong climber who can time trial AND sprint. To earn his top UCI ranking, he won Liège-Bastogne-Liège, the 2008 Critérium du Dauphiné Libéré and the Spanish National Road Race Championship. He won Grand Tour Stages and the Vuelta a Murcia. In 2009, he won the Dauphiné again.
Valverde, at 29, is at the peak of his powers. He may well win the Vuelta a España, where he is, at time of writing, wearing the leader’s golden jersey. But what will it mean for the rider known as the Bala Verde(Green Bullet) if he does win? What will it mean for his team, Caisse d’Epargne? And what will it mean for pro cycling? There remains an elephant in the peloton.
What follows are facts: 1) Valverde rode for the Kelme team from 2002-2004. 2) During that time, Kelme’s riders were being cared for by Dr Eufemiano Fuentes. 3) In 2006, Fuentes was arrested after a large cache of blood bags, suspected to contain the blood of doped athletes, was found in his Madrid clinic. 4) The resulting scandal, known as Operación Puerto, implicated dozens of riders in the pro peloton. 5) In 2009, the Italian Olympic Committee professed to have linked one of the bags of blood, labelled “valv.piti” to Valverde, and subsequently brought the Spaniard to Italy to face doping charges. 6) Valverde maintained his innocence, but was banned from competing in Italy for two years anyway, which caused him to miss the Tour de France. 7) Valverde has filed an appeal to the Court of Arbitration of Sport with the hope of overturning his Italian ban and clearing his name. 8) A Spanish judge has sealed the evidence in the Operación Puerto case, preventing both Italian and cycling authorities from moving forward with prosecutions of any implicated riders.
Judge Antonio Serrano, who has presided in often controversial fashion over the Puerto case, has hewn closely to the letter of the Spanish law. It seems that at the time of the raid on Fuentes’ clinic, the substances allegedly found in only a handful of the blood samples, were not in fact illegal in Spain. Serrano has, for that reason, closed the case against Fuentes and his co-defendants repeatedly. That the alleged doping agents are illegal under the laws of the UCI doesn’t trouble Serrano in the least. The thinking is that, since no laws were broken prior to the collection of the evidence, the evidence was seized unlawfully. Further, the handling of the blood by authorities has been problematic in its own right. The Italian Olympic Committee claims it has a bag of blood from Fuentes’ clinic and has matched it to Valverde. Quite how they got that blood, how it was handled and what jurisdiction they have over a Spanish rider involved in a closed Spanish court case are all questions hanging heavy in the air.
We know the following for sure: 1) The case against Valverde is largely circumstantial, because the blood in the bag alleged to be his has not been matched to a DNA sample submitted by the rider, and whether you believe his denials or not, he continues to ride, confident that he can clear his name. 2) While the Italian Olympic Committe, who take an active role in doping investigations in Italy, have banned him, the Spaniard has challenged their jurisdiction over his case, as any offenses purportedly occurred in Spain.
What follows is conjecture: 1) The UCI is said to be disappointed that the Spanish courts have sealed the case records, but it is entirely possible that they simply want to appear disappointed, because if, as suspected, the number and caliber of riders (close to 50) involved were all suspended, it would decimate the ProTour. 2) It is possible that Valverde was storing blood with Fuentes without having used it. He may have done what Ivan Basso eventually admitted to in the same Puerto case, which is “intending to dope.” 3) By continuing to ride and be tested, Valverde may be building a case for his innocence based on “clean” wins, that is, wins without positive dope tests. 4) If the Italians had actual proof, i.e. a DNA sample they could match to the bag of blood, then they presumably would have turned that evidence over to the UCI, which would effectively end Valverde’s efforts to clear himself. That the Italians haven’t done so, implies that their case is, in fact, only circumstantial.
If Valverde wins the Vuelta, there are two possible scenarios that could play out, each with drastically different consequences. First, it’s possible that a Valverde win will force all of this to be rehashed in the press, and perhaps more pressure will mount on the Spanish courts to release the case material, which would, of course unleash pandemonium, a pandemonium that’s been hibernating since 2006. This chain of events would take us back to Floyd Landis being stripped of his Tour de France win, of Michael Rasmussen being kicked out of the Tour while wearing the yellow jersey. It would indict the sport anew and quite possibly end Caisse d’Epargne and Valverde all in one fell swoop. It might put paid to the idea that the current testing program is sufficient. If Valverde, a rider many believe to have doped, can win without a positive, in competition test, then it’s fair to ask how effective the testing regime really is. Regardless, this is not what pro cycling needs, in what all of us hope is a new era of transparency and fairness.
Or, perhaps winning a Grand Tour without testing positive for EPO or CERA or testosterone or excess Nutella, will convince both the authorities and the fans that digging into the Puerto vault serves no real purpose. Valverde’s taken his lumps. Maybe he can move on now. Maybe we can all move on, forgiving dopers their past and celebrating the techniques and results of the teams who have taken on programs built around racing clean.
To be sure, someone, somewhere, at some point, is going to have to comprehensively address this latest elephant in the room. It remains to be seen whether the elephant will stand up and make his own presence felt, or whether he’ll simply slink out the back door leaving nothing but a vague odor and a deep dent in the couch.
Image: John Pierce, Photosport International